Hyperliquid Strategies Inc. (NasdaqCM: PURR)
Health Care · Biotechnology · US
$10.58
+4.96% today · +171.3% 1Y
Hyperliquid Strategies Inc. (NasdaqCM: PURR) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.42B and employs 9 people.
Over the last twelve months the share price has gained 171.3%, trading between 3.01 and 11.62.
PURR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.42B
- Revenue (TTM)
- —
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $11.62
- 52-week low
- $3.01
- Avg volume (3M)
- —
- Shares outstanding
- 134.62M
- Employees
- 9
- Next earnings
- —
About Hyperliquid Strategies Inc.
Hyperliquid Strategies, Inc. operates as both a holding and an active management firm, specializing in the oversight of crypto assets. The company functions primarily as a digital asset treasury, with a dedicated focus on the Hyperliquid ecosystem. Established on July 2, 2025, its corporate headquarters are situated in New York, NY.
- Founded
- 2025
- Listed since
- Dec 2, 2025
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $265.85 | +0.34% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $439.79 | +0.10% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.96 | +0.57% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.19 | +0.03% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $842.16 | +0.97% |
| argenx SEENXTBR: ARGX | $65.85B | €880.20 | -2.42% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $143.76 | -0.90% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.